Madrigal Pharmaceuticals Inc (MDGL)
SG&A Expense Growth
7.77%
Quarterly · Period ending:
MDGL SG&A Expense Growth
Latest reported7.77%period ending
Latest reported7.77%period ending
MDGL Quarterly SG&A Growth (QoQ) (0.00% → 7.77%)
Latest values, visible window
High-resolution chart · PNG
MDGL sg&a expense growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | SG&A Expense Growth |
|---|---|
| 7.7662% | |
| 11.8949% | |
| 14.7568% | |
| 6.2273% | |
| 17.2639% | |
| 18.873% | |
| 31.2664% | |
| 2.0266% | |
| 30.505% | |
| 73.629% | |
| 68.7126% | |
| 54.5699% | |
| 10.2769% | |
| 11.163% | |
| 19.8995% | |
| 3.117% | |
| 21.9093% | |
| -17.5376% | |
| 41.3298% | |
| -18.0317% | |
| 40.2414% | |
| 17.6787% | |
| 11.5035% | |
| -2.5714% | |
| 22.4539% | |
| -8.7034% | |
| 6.2342% | |
| -33.2208% | |
| 23.7383% | |
| 2.9196% | |
| 9.0004% | |
| 88.5167% | |
| 45.2165% | |
| -22.0092% | |
| 22.711% | |
| 20.4559% | |
| -4.2478% | |
| -24.0591% | |
| -64.4925% | |
| 75% | |
| 18.1579% | |
| -2.9994% | |
| 5.1325% | |
| -4.669% | |
| -24.6506% | |
| -2.1457% | |
| 30.8547% | |
| 10.2381% | |
| -44.7784% | |
| 53.7395% | |
| -16.9743% | |
| -0.3821% | |
| 7.968% | |
| 15.6921% | |
| 19.8856% | |
| -2.984% | |
| 8.9191% | |
| -5.6011% | |
| -10.4759% | |
| 6.2797% | |
| 10.2132% | |
| -12.5327% | |
| 17.9467% | |
| -4.6024% | |
| -11.9896% | |
| 27.1529% | |
| -22.9279% | |
| 4.792% | |
| -26.1671% | |
| 17.2911% | |
| -5.3206% | |
| -7.7755% | |
| 9.3862% | |
| -3.1716% | |
| -2.5961% | |
| -0.026% | |
| 75.9361% | |
| -11.5866% | |
| 22.8671% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| -100% | |
| 0% | |
| 0% |